Our earlier identification of the non-structural protein 3 (NS3) of Japanese encephalitis virus (JEV) as a dominant CD4
INTRODUCTION
The genus Flavivirus belonging to the family Flaviviridae includes many arthropod-transmitted viral pathogens including the dengue viruses, Murray Valley encephalitis virus, Japanese encephalitis virus (JEV), tick-borne encephalitis virus complex, yellow fever virus and West Nile virus. Among the medically important flaviviruses, JEV, which causes acute encephalitis in humans, has the highest mortality rate and is one of the chief threats to public health in several parts of Asia (Tsai et al., 1999) . While the disease incidence has been reduced to low levels in developed countries such as Japan, Korea and Taiwan, principally due to routine childhood immunization, JEV remains the most important cause of acute epidemic viral encephalitis worldwide and continues to expand its geographic domain to previously unaffected areas like Indonesia and continental Australia (Mackenzie et al., 2001 (Mackenzie et al., , 2002 . One of the major problems with the above-mentioned internationally licensed mouse brainderived inactivated JEV vaccine is the lack of long-term immunity necessitating repeated booster doses for effective reduction in disease rates (Ku et al., 1994) . The success of the live attenuated yellow fever virus vaccine, which has an excellent record of safety and effectiveness with life-long immunity (memory) achieved by administration of a single dose (Monath, 1999) , is probably attributable to the generation of T cell help required for effective induction of quick and enhanced magnitudes of antiviral B and T cell responses. Identification of T cell epitopes that are immunogenic in viral infections could thus be of immense value in designing vaccine vectors that can supersede the use, and thereby the inherent risks involved, of live attenuated viruses, which are currently the ideal vaccine candidates by virtue of their close resemblance to natural virus infections.
There have been indications from previous reports that human anti-JEV-specific T cells produced during natural infection target predominantly the viral non-structural proteins (produced only during live virus infections) and not the structural proteins (the major constituent of the killed JEV vaccine) (Konishi et al., 1995; Desai et al., 1995; Kumar et al., 2003b) . The cell-mediated immune parameters that contribute towards protection against JEV can be investigated in individuals who have experienced subclinical infections of JEV and in whom, therefore, development of immune responses prevented virus invasion into the central nervous system and consequently fulminant encephalitis. To broaden our understanding of the T cell responses in JEV infections and their potential role in resistance and recovery, we had carried out a screen in healthy individuals from JEendemic areas of South India for T cell target antigens wherein the non-structural protein 3 (NS3) of JEV scored as a highly immunogenic antigen with nearly 86 % of the cohort displaying Th1 responses to this protein. Analysis of the responding T cell frequencies revealed activation of mainly CD4
+ T cells ascribable to the antigen preparation used, i.e. fixed lysates of recombinant baculovirus-infected Sf21 cells expressing the NS3 protein (Kumar et al., 2003b) . A comparison of the antigenicity of these proteins of JEV provided in the form of fusions to the 11 amino acid (aa) human immunodeficiency virus (HIV) TAT protein transduction domain (PTD; YGRKKRRQRRR), to ensure the intracellular delivery of protein upon exogenous addition of antigen via transduction across cell membranes, also revealed a dominant recognition of NS3 in 96 % of a cohort of children with a previous incidence of JEV subclinical infections (Kumar et al., 2004a) . In the present study, we used truncated versions of the NS3 protein to show that in most of the JEV-exposed children who formed our cohort, almost the entire NS3-specific T cell response (inclusive of CD4 + and CD8 + ) localized to an immunodominant region between aa 193 and 324.
METHODS
Cells and viruses. The JEV P20778 strain (National Centre for Cell Science, Pune, India) was propagated in the Aedes albopictus cell line C6/36 at 28 uC and in Vero cells at 37 uC in minimal essential medium supplemented with 10 % fetal bovine serum.
Construction of recombinant proteins fused to HIV TAT.
Purified viral genomic RNA extracted from JEV-infected C6/36 cells was reverse-transcribed and the 1857 nt long NS3 gene (4608-6464 nt in the JEV genome) PCR amplified using the Expand RT system (Roche Diagnostics) with the following primer pairs (start and stop codons in bold, restriction sites underlined): NS3 sense, 59-GGATACTCGAGCATATGGGGGGCGTGTTTTGGGACAC-39 (XhoI); NS3 antisense, 59-CGCGCGAATCCTTATCTCTTCCCTGCTGCAA-AGTCTTT-39 (EcoRI). The PCR-amplified NS3 gene was digested with XhoI and EcoRI and cloned into the corresponding sites of the bacterial expression vector pTAT-HA (a kind gift from Steven F. Dowdy, Howard Hughes Medical Institute, St Louis, MO, USA) in frame with the N-terminal six-histidine leader, 11 aa PTD of HIV TAT protein and a haemagglutinin tag provided by the vector (Becker-Hapak et al., 2001) to give pTAT-NS3. Various N-or Cterminally deleted versions and internal fragments of JEV NS3 generated with all forward primers containing a XhoI site and a start ATG codon and reverse primers with an EcoRI site and a stop codon were identically cloned. Similarly expressed and purified unrelated green fluorescent protein (GFP) was the control antigen. Recombinant TAT fusion proteins expressed in E. coli BL21 (DE3) were purified by electroelution from SDS-polyacrylamide gels, precipitated and solubilized in PBS. All proteins were tested for purity by N-terminal sequencing of the electroeluted protein using Edman chemistry, endotoxin absence using the Pyrogent plus Gel-clot LAL test kit (BioWhittaker) and finally their ability to transduce into lymphocytes before use in assays.
Human peripheral blood mononuclear cells (PBMC). Peripheral blood specimens were obtained from children belonging to the JE-endemic regions of the states of Karnataka and Andhra Pradesh between August 2002 and January 2003 at the district hospital, Vijayanagar Institute of Medical Sciences, Bellary, Karnataka, India. Twenty-six healthy non-vaccinated JEV-seropositive children (15 males, 11 females, 5-16 years old, mean age 9?6±0?6 years) with no history of clinical encephalitis, but with >1 log 10 serum plaque reduction neutralization test (PRNT) antibody titres to JEV (Rao-Bhau et al., 1988; Ting et al., 2001) , as well as serum antibodies to non-structural proteins by radioimmunoprecipitation (Kumar et al., 2003b) , constituted the test group having experienced previous subclinical JEV infections. Serum PRNT-ELISAs to dengue and West Nile viruses were confirmed to be negative (<0?4 log 10 ). Volunteers V1-V8, V10, V11, V15, V16, V18, V21 and V22 were also included in our previous study cohort (Kumar et al., 2004a) and have been designated the same numbers. Volunteers V25-V35 were recruited only for this study. The control group also formed part of our previous study (Kumar et al., 2004a) . This group included 12 healthy non-vaccinated children with no history of clinical encephalitis, with a similar age and sex distribution (7 males, 5 females; 6-11 years old, mean age 8?1±0?4 years) and <0?2 log 10 serum-PRNT titres to all three flaviviruses. Measles, tuberculosis, hepatitis and HIV/AIDS were all ruled out in the study population. Blood was drawn following informed consent of the guardians of the children in the study after explaining the purpose and consequences of the investigation. All the procedures and protocols were conducted in conformity with the ethical guidelines of the Indian Council of Medical Research.
Proliferative responses of PBMC. Proliferation assays were performed as previously described (Kumar et al., 2003b) . PBMC (1?56 10 5 ) were cultured with total JEV proteins (VJE) at a concentration equivalent to 16 ng E protein per well (Aihara et al., 1998; Kumar et al., 2003b) or purified recombinant TAT peptide fusion proteins, i.e. NS3 at the optimal concentration of 50 mg ml 21 (0?7 mM) or truncated proteins at molar concentrations equivalent to that of fulllength NS3. Uninfected Vero cell lysates (VUI) and GFP also provided as a TAT peptide fusion were the control antigens. Proliferative response was expressed as stimulation index (SI), the ratio of the mean c.p.m. incorporated by PBMC in triplicate wells in the presence of test and control antigens. We scored a positive response to viral antigens based on the criteria that: (i) the SI¢3?0 since the highest SI value in control individuals in response to the test antigen plus 1?96 times the SD of the mean was <2?5; and (ii) the mean c.p.m. obtained on stimulation with viral antigen was ¢500. Recovery of and counts incorporated by PBMC from blood of donors of both groups was similar.
Interferon (IFN)-c ELISA. IFN-c in 3 day culture supernatants was assayed using commercial capture ELISA kits (Endogen). The lower limit of detection was 15 pg cytokine ml 21 .
Flow cytometry. Antigenic stimulation of 0?5 ml whole blood was carried out as previously described (Kumar et al., 2003a) with 50 mg of recombinant NS3 (at the optimal concentration of 1?4 mM) or No positive staining was observed with matched isotype control antibodies.
equivalent concentrations of , all provided as fusions to the TAT peptide, for 6 h at 37 uC with 3 mM monensin included during the last 4 h. Intracellular IFN-c was detected using an antibody cocktail made up of anti-CD3-FITC, anti-CD4/CD8-phycoerythrin and anti-IFN-c-biotin followed by Streptavidin-CyChrome (BD Biosciences Pharmingen). Data were acquired on a Becton Dickinson FACScan flow cytometer. For each analysis, a total of 50 000 CD3
+ CD8 + T cell subsets were acquired and data were analysed using Winlist software (Verity Software House Inc., Topsham, ME, USA). Positive staining was determined after comparing data with that obtained using isotype-matched controls and by comparing dot plots of test and control antigen-stimulated cultures.
HLA typing. PBMC of JEV-exposed donors were typed for HLA by microlymphocytotoxicity using HLA typing trays purchased from Biotest.
Measurement of protein variability. NS3 protein sequences of 37 independently isolated flaviviruses including 11 dengue, 16 JEV, one Kunjin, one Murray Valley encephalitis, six West Nile and two yellow fever virus isolates (GenBank accession nos P14340, A42551, GNWVD3, GNWVDF, GNWV26, GNWVJA, P27914, AAK29447, AAG30730, AAK67712, AAA42964, U15763, M55506, U47032, M18370, AF080251, L48961, AAL77444, AF014160, AF014161, AF069076, AAD16275, AAD16276, AAD16277, AF045551, AF075723, GNWVKV, On: Mon, 07 Jan 2019 09:53:30 AF217620, NP_722535, AAP20887, P06935, AAK06624, AAG02040, AAG02039, AAF18443, NP_776005 and AAA99713, respectively) were aligned using the Bioedit Sequence Alignment Editor version 5.0.9 (Hall, 1999) . A Shannon entropy score was then calculated for each position in the protein alignment using the same program to obtain a measure of the amino acid variability at a given position taking into account both the number of possible amino acids allowed and their frequency (calculated as SP aa logP aa , where P aa is the proportion of each amino acid in the respective position) (Yusim et al., 2002) . To examine the relative levels of variability over the entire NS3 protein sequence, the entropy scores were smoothed by averaging over a window of 9 aa, the typical size of an epitope binding to HLA class I molecules, and individual as well as smoothed scores for each amino acid position in each overlapping window was determined. Positions where the majority of the sequences had gaps were excluded from consideration (Yusim et al., 2002) . When only a minority of sequences (less than eight) had gaps, however, the position was included and the gaps were treated as separate symbols.
Statistical analysis. Results of lymphoproliferation and ELISA are represented as mean SI values and pg ml 21 , respectively, ±SEM. All analyses were performed with GraphPad Prism version 3.00 for Windows (GraphPad Software) at a significance of P<0?05. The non-parametric Mann-Whitney U test was used to compare the two groups, the Wilcoxon rank sum test for paired measurements for comparison between antigens and the Freidman test for comparison between three or more matched groups, as appropriate. Correlations were quantified using Spearman's rank correlation coefficient. The age and sex of the study individuals were found not to influence the parameters measured as analysed by logistic regression.
RESULTS

Memory T cell responses to stimulation with JEV antigen
PBMC from healthy children with >1 log 10 PRNT titres to JEV (range 1?10-3?11) and serum antibodies to NS3 indicative of a prior subclinical infection with the virus were stimulated with total proteins from JEV. All donor PBMC exhibited positive proliferation (SI¢3?0, range 3?2-19?5) to JEV antigen pointing to the priming of virus-specific T cells during a prior subclinical infection (Fig. 1A) , while minimal proliferation was induced in control PBMC. As described by us previously, most of the JEV-exposed donors analysed in two independent, non-overlapping cohorts also displayed dominant T cell reactivity to the NS3 protein of JEV (Kumar et al., 2003b (Kumar et al., , 2004a . NS3-specific CD4 + as well as CD8 + T cells secreted significant levels of the type 1 cytokine IFN-c when NS3 was provided as a TAT fusion whose ability to translocate into the cytoplasm of PBMC was established by flow cytometry and confocal microscopy (Kumar et al., 2004a) . In the cohort under consideration, the dominant antigenicity of NS3 was again reinforced by a 96?2 % frequency of recognition, since it induced proliferative responses in all but one donor (mean SI 7?5±0?7; Fig. 1A ).
We initially screened for responses to the first 324 (NS3 1-324 ) or last 296 (NS3 324-619 ) aa of NS3 in 16 donors with NS3-specific responses. Proliferation levels to NS3 1-324 exceeded 70 % of that elicited by the full-length protein in 13 of the 15 responders to NS3 1-324 (Fig. 1B) . In contrast, PBMC from 12 of these 13 donors did not respond to NS3 324-619 (SI<3?0). Measurement of secreted IFN-c levels revealed a similar picture, with NS3 324-619 stimulating <100 pg IFN-c secretion ml 21 from PBMC of 10 donors and <30 % of the total NS3-induced IFN-c in PBMC from all but V32, whose response alone was directed only towards NS3 (Fig. 1C) . Both halves of NS3 contributed to total IFN-c in V26, V28 and V35. Thus, the first 324 aa of NS3 appeared to contain the most immunogenic epitope(s) targeted by T cells during natural infections with JEV.
Mapping of immunogenic regions of NS3 using truncated versions of the protein
Phenotypic analysis of NS3-specific T cells from V25 and V31, both of whom displayed impressive responses to only the first half of NS3, revealed high proportions of IFN-cproducing CD4
+ as well as CD8 + T cells (Fig. 2) , indicating that NS3 contained epitopes recognized by both subsets of T cells in these donors. Furthermore, both these donors were found to completely differ in their class I HLA alleles (Fig. 2) pointing to the presence of at least two distinct class I epitopes in NS3. To demarcate the epitope-bearing regions of NS3, six N-terminal and two C-terminal NS3 fragments along with four additional internal stretches of the NS3 protein, designated according to the boundary amino acids, were generated and purified as TAT fusion proteins (Fig. 3A) to examine their in vitro lymphocyte-stimulating capacity in V25 and V31.
Progressive truncation of the NS3 protein from aa 619 to aa 324 did not significantly reduce the proliferative response in either donor (Fig. 3B) . Further reduction to aa 193 totally abrogated responses in V25, while in V31, NS3 1-193 evoked significantly reduced responses, which further declined to minimal levels with NS3 1-147 . Thus aa 193-324 houses epitopes recognized in both these individuals. These observations were further corroborated using N-terminal truncations and internal regions of NS3 (Fig. 3B) . Predictably, only proteins NS3 107-619 , NS3 107-324 and NS3 193-324 successfully stimulated PBMC, the latter containing only the amino acid stretch under investigation, eliciting maximal SI values comparable with those attained with the full-length protein.
The levels of IFN-c produced followed the trend observed in SI values for each of the NS3 truncations (Fig. 3B) . NS3 193-324 induced maximal IFN-c production (2800 and 5200 pg ml 21 compared with 1400 and 2972 pg ml 21 observed with NS3 in V25 and V32, respectively) at a molar concentration equivalent to that of full-length NS3, probably reflecting an increased efficiency in processing of this smaller protein stretch. In view of the dissimilar HLA alleles in these two individuals, these results point to the presence of more than one T cell epitope between aa 193 and 324 of NS3.
Aa 193-324 of JEV NS3 protein dominate in their ability to stimulate PBMC from the majority of JEV-exposed individuals
We investigated the potential of NS3 to stimulate PBMC of the 26 children who formed our JEV-exposed cohort. (Fig. 1B) , no significant differences could be noted in mean levels of the measured parameters to the full-length, the first half and aa 193-324 of NS3 (Fig. 4C, P>0 (Table 1) . Moderate reductions in frequencies of either or both T cell subtypes occurred in V5, V27, V28 and V35 suggestive of minor contributions from recognition of epitopes elsewhere in NS3. Haplotyping of the class I alleles of volunteers whose target epitopes lay within NS3 193-324 revealed 12 HLA A, 12 HLA B and 5 HLA C alleles. The existence of at least three volunteers with no common HLA alleles whose CD4 + and CD8 + T cells recognized NS3 pointed to a minimum of three epitopes restricted by independent class I alleles and at least one class II epitope mapping to this region of NS3. V32, whose PBMC alone did not respond to NS3 , had a single HLA allele [A26(10)] that was not found in any other donor, suggesting that this donor's weak CD8 + T cell response to NS3 (Table 1) was restricted by this allele.
Analysis of the relationship between amino acid variability and occurrence of T cell epitopes
The fact that NS3 was an antigenic target of T cells from individuals with diverse HLA haplotypes was considered to be a feature worth investigating, especially since any variation in sequence of the infecting strain would influence the assessment of these immune responses. To evaluate links, if any, between sequence variability of NS3 and virus-specific T cell responses, we assessed the relative variability of NS3 by aligning the amino acid sequences of this protein from 16 different isolates of JEV. The mean entropy of all positions of the protein was estimated by taking into account both the frequency and spectrum of amino acids at each position. Site-by-site analysis revealed only 50 positions of variability in the 619 aa long NS3, reflecting the highly conserved nature of this protein (Fig. 6A) . Remarkably, the largest stretch of the protein that recorded absolutely no variation in any of the 16 sequences compared was found to be aa 219-318, which interestingly was encompassed within aa 193-324 of NS3. The documented existence of flavivirus cross-reactive epitopes prompted us to align and compare the variability of NS3 sequences across 37 different flaviviruses including dengue, JEV, Murray Valley encephalitis virus, West Nile virus and yellow fever virus. Since variability was highly nonuniform within different flavivirus NS3 protein sequences, we calculated regional entropy scores averaged over a 9 aa window, the size of a typical class I epitope. Again, the smoothed entropy scores were least in the region corresponding to aa 193-324 (Fig. 6B) , with the mean entropy of this region scoring lower than that for an equivalent length of any other region in NS3 or the entire NS3 itself. Calculation of entropy scores smoothed over a window of 20 aa, so as to include class I as well as class II epitopes, yielded typically similar results with aa 193-324 again ranked the lowest (data not shown).
DISCUSSION
Following our earlier observation that NS3-specific T cells producing IFN-c were present in a vast majority of healthy exposed individuals of varied HLA haplotypes from a JEendemic region, it was of particular interest to investigate the distribution of epitopes responsible for CD4 + and CD8 + T cell responses on this protein. Our approach of using NS3 segments fused to the TAT peptide of HIV, thus enabling detection of both subsets of T cells, identified a single, highly immunodominant region comprising aa 193-324 of NS3 as primarily responsible for stimulating T cells in two healthy JEV-exposed children with different class I HLA haplotypes. NS3 193-324 elicited a Th1 response in more than 88 % of the volunteers, often more efficiently than the parent protein, presumably due to improved processing and consequent presentation of this smaller protein. It was indeed noteworthy that the phenotype of T cells responding to the full-length NS3 and the 132 aa segment were almost identical, both qualitatively and quantitatively. Th1 responses to NS3 were mediated by CD4 + as well as CD8 + T cells, revealing the presence in this segment of both class I and II epitopes that are processed and presented during the natural course of JEV infection. Moreover, this region was highly conserved, with absolutely no change in aa 210-318 among 16 different strains of JEV. The high a-helicity of this stretch (53?44 %, data not shown) is in consonance with the known propensity of T cell epitopes to lie within a-helical regions of proteins (Yusim et al., 2002) . NS3, one of the most conserved proteins among flaviviruses (Billoir et al., 2000) , is known to perform the functions of a protease, nucleoside triphosphatase and helicase (Rice & Lindenbach, 2001 ). The first 180 aa residues of NS3 contain the catalytic triad required for its trypsin-like protease activity, while the region C-terminal to this contains conserved motifs found in the nucleoside triphosphate-binding proteins and DexH family of RNA helicases, the last function being implicated in an unwinding step during genomic RNA replication. Of the seven motifs that are characteristic of RNA helicases of the DexH subfamily, four map to aa 193-324 of NS3 (Fig. 6C) (Lin & Kim, 1999) . In addition, the conserved TxGx/CHAT and SIAARG motifs (Billoir et al., 2000) also map to this region. Mutations within as well as just outside any of these conserved motifs have been known to have deleterious effects ranging from non-viability/ altered phenotype of flaviviruses to slow replication rates/ attenuation (Lin & Kim, 1999; Matusan et al., 2001) , justifying the high conservation of aa 193-324 of NS3.
The flavivirus NS3 protein has been a dominant source of antigenic peptides in the mouse model (Lobigs et al., 1994) . Studies on the human cell-mediated immune response to dengue and yellow fever viral proteins have also identified NS3 as a predominant target for both CD4 + and CD8 + T cells in vaccine recipients as well as in natural infections. It was interesting to note that several epitopes bound by HLA A24, B07, B35, B38, B62, DPw2 and DR15 have all been mapped to the region corresponding to aa 193-324 of NS3 (Kurane et al., 1993 (Kurane et al., , 1995 Mathew et al., 1996 Mathew et al., , 1998 Zeng et al., 1996; Okamoto et al., 1998; Zivny et al., 1999; Loke et al., 2001; Co et al., 2002; Zivna et al., 2002) . When we aligned the positions of these experimentally identified epitopes in the NS3 protein with the smoothed entropy scores, the region corresponding to aa 193-324 of NS3 harboured nine of the 16 identified epitopes, both class I and II, restricted by at least five different HLA alleles ( Fig. 6B) . Notably, each of the experimentally defined epitopes mapped with striking regularity to regions with a dip in entropy, revealing the concentration of epitopes of varied HLA specificities in conserved regions within the aa 193-324 segment of NS3.
Some of the dengue virus NS3 epitopes mentioned above are cross-reactive and were recognized by human CD8 + or CD4 + T cell clones specific for not just the four different serotypes of dengue virus, but also other flaviviruses such as West Nile virus and yellow fever virus. According to a recent report, cytotoxic T cells against two immunodominant H-2K k -restricted determinants on the Murray Valley encephalitis virus NS3 lysed target cells pulsed with peptides from the corresponding amino acid stretches on NS3 of six other flaviviruses including JEV (Regner et al., 2001) . Extremely immunogenic T helper cell epitopes have been identified in the core, NS3 and NS4 proteins of the related hepatitis C virus, which, besides being highly conserved among the known isolates, were also found to be very promiscuous because they could be presented to T cells by several different class II alleles (Diepolder et al., 1997; Lamonaca et al., 1999) . Similarly, naturally processed viral peptides have also been known to be presented in the context of two or more class I alleles (Tomiyama et al., 2000; Thimme et al., 2001) . Fine mapping of the T cell epitopes in this segment currently underway should help to resolve the question of whether the high recognition frequency of NS3 193-324 might also be ascribed, among other reasons, to similar promiscuity.
A likely contributing factor to the identification of immunoreactive peptides in this region could be a selection effect, as T cells that target variable regions may go undetected due to sequence substitutions in reagents used to define the T cell response. Thus, the decrease in immunogenic potential of the variable regions in NS3 may reflect past immune escape concentrated in regions of the virus that readily tolerate change or might ensue from actual clustering of epitopes in the relatively conserved regions. The former possibility, however, appears unlikely in view of the reasonably high degree of conservation observed in other regions, especially the second half of NS3, despite which this region was targeted in only a few of the donors with NS3 reactivity. In addition, the mean rate of non-synonymous (amino acidchanging) substitutions for mosquito-borne flaviviruses (7?5610 25 year 21 ; Zanotto et al., 1996) is nearly 200 times less than that observed in a highly mutating virus such as HIV (3?9610 23 year
21
; Li et al., 1988) , where clustering of epitopes in relatively conserved regions of various proteins is a recognized phenomenon (Yusim et al., 2002) . Hence, despite possible reference strain experimental bias, there could be additional as-yet-unidentified immunological reasons that account for the paucity of epitopes in variable regions of NS3. We are tempted to speculate that the low incidence of symptomatic JEV infections (1 in every 250 infected individuals) could be due to the restricted spread of the virus in the periphery on account of selective targeting by the immune system of regions in viral proteins that cannot tolerate change in sequence owing to their crucial function.
Our earlier studies have implicated a role for IFN-c in recovery from encephalitis in JEV patients (Kumar et al., 2004b) . That NS3 193-324 also elicits this antiviral Th1 cytokine in healthy individuals residing in endemic areas who represent a 'naturally immunized' population makes it an important correlate of protective immunity to JEV. NS3 is one of the most conserved proteins among different strains of JEV and among flaviviruses, which enhances the probability that the highly antigenic aa 193-324 stretch may be recognized by T cells against different strains of not only JEV but also other flaviviruses. Therefore, incorporation of this highly immunodominant region from one of the most conserved proteins of flaviviruses in immunizing preparations would help in the development of a highly crossreactive flavivirus vaccine, capable not only of eliciting CD8 + T cells required for ultimate virus clearance, but also in providing T cell help for long-lasting neutralizing antibody generation, a mechanism that is believed to be crucial for protective immunity against JEV (Pan et al., 2001 ). In conclusion, immunodominance, sequence conservation and probable cross-reactivity make the stretch of amino acids from aa 193 to 324 of NS3 an ideal additive to a humoral response-eliciting vaccine against JEV. 
